DEFSEC Technologies Inc. - common stock, no R/S concurrent with offering DFSC 深 滬
已收盤 12-05 16:00:00 美东时间
3.72
-0.090
-2.36%
華盛通- 最 高4.14
- 今 開3.84
- 成交量 20.22万股
- 最 低 3.6333
- 昨 收 3.81
- 總市值 519.42万
- 52周最高 31.50
- 市盈率 靜 --
- 換手率 0.01%
- 52周最低 0.184
- 委 比 18.64%
- 總股本 139.63万
- 歷史最高 819.00
- 量 比 7.04
- 振 幅 13.30%
- 歷史最低 0.184
- 每 手 1
- 風險率 3.76%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Industrials Stocks Moving In Friday's Pre-Market Session
Gainers ChargePoint Hldgs (NYSE:CHPT) shares moved upwards by 10.1% to $9.38 d...
12-05 20:05
DEFSEC Adds 15 More Government Tech Roles, Boosting Annual Billings to C$8.3M and Gross Margins to C$2.3M Starting February 2026
DEFSEC Technologies Inc. (TSXV:DFSC) (TSXV:DFSC) (NASDAQ:DFSC) (NASDAQ:DFSCW) ("DEFSEC" or the "Company") is pleased to announce significant momentum in its government services business as it expects to add an additional
12-05 20:03
12 Industrials Stocks Moving In Friday's Pre-Market Session
Gainers DEFSEC Technologies (NASDAQ:DFSC) shares moved upwards by 29.2% to $5....
10-31 20:10
Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Shares of Amazon.com Inc (NASDAQ:AMZN) rose sharply in today's pre-market tradi...
10-31 17:31
12 Industrials Stocks Moving In Wednesday's After-Market Session
Gainers JB Hunt Transport Servs (NASDAQ:JBHT) stock rose 11.2% to $154.6 durin...
10-16 05:06
12 Industrials Stocks Moving In Friday's Intraday Session
Gainers Professional Diversity (NASDAQ:IPDN) shares rose 446.1% to $10.54 duri...
08-30 01:05
DEFSEC Technologies Completes CAD$6.8 Million Public Offering
An announcement from DEFSEC Technologies ( ($TSE:DFSC) ) is now available. On A...
08-08 23:57
DEFSEC Technologies closes $6.8M public offering
DEFSEC Technologies (NASDAQ:DFSC) (TSXV:DFSC:CA) completed a public offering of 759,879 common shares or pre-funded warrants and accompanying share purchase warrants. Combined offering price was CAD$8...
08-08 21:11
NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results
NextCure, Inc., a clinical-stage biopharmaceutical company focused on developing novel cancer therapies, announced strategic progress in their ADC programs SIM0505 (targeting CDH6) and LNCB74 (targeting B7-H4). NextCure plans to dose the first SIM0505 patient in the U.S. this quarter and provide updates on both programs by Q4 2025, along with proof of concept data in H1 2026. Financially, the company reported a net loss of $26.8 million for Q2 20...
08-07 20:05
DEFSEC Technologies Announces CAD$6.8 Million Public Offering
An update from DEFSEC Technologies ( ($TSE:DFSC) ) is now available. On July 24...
07-25 03:19
